All proposals approved at 10x Genomics 2026 annual meeting: directors elected, auditor ratified, say-on-pay passes

10x Genomics, Inc.

Serge Saxonov, Benjamin Hindson, and John Stuelpnagel elected as Class I directors with ~91% of votes cast (excluding broker non-votes).
Ratification of Ernst & Young as independent auditor for FY2026 approved with ~99.4% of votes cast.
Non-binding advisory vote on executive compensation approved with ~98.4% of votes cast (excluding broker non-votes).
Approx. 90.5% of eligible votes represented at the meeting; 117.5M shares present.

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

10x Genomics, Inc. shareholders approved Election of three Class I directors at the 2026-06-04 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-04

Exact text from the filing

Nominee Votes For Votes Against Abstentions Broker Non-Votes Serge Saxonov 164,137,381 15,559,860 557,329 18,560,948 Benjamin J. Hindson 162,942,766 16,761,532 550,270 18,560,950 John R. Stuelpnagel 155,628,365 24,072,179 554,023 18,560,951

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

10x Genomics, Inc. shareholders approved Non-binding advisory vote to approve executive compensation of named executive officers at the 2026-06-04 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-06-04

Exact text from the filing

Votes For Votes Against Abstentions Broker Non-Votes 176,677,540 2,828,730 748,296 18,560,952

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

10x Genomics, Inc. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-04 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-04

Exact text from the filing

Votes For Votes Against Abstentions Broker Non-Votes 197,719,939 458,231 637,346 —

View on SEC.gov

995 shareholder votes filed in the last 30 days. Browse all shareholder votes →

10x Genomics, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-041651

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.